| RS1555609402 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1555609514 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS1555609798 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS1555609899 |
FLCN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS1555610241 |
PGAP3
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 4, Hyperphosphatasia with intellectual disability syndrome 4 |
| RS1555610290 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1555610292 |
PGAP3
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 4, Hyperphosphatasia with intellectual disability syndrome 4 |
| RS1555610590 |
NXN
|
Health Risk |
Likely pathogenic |
Distal shortening of limbs, Robinow syndrome |
| RS1555610774 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555610848 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555610854 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555610855 |
GRN
|
Health Risk |
Pathogenic/Likely pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS1555610860 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555610879 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1555610881 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555610884 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555610893 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555610896 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555610898 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555610900 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555610903 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555610905 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555610907 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS1555610910 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555610916 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555610955 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555610971 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555610972 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555610984 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555611004 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555611037 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1555611039 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555611043 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555611089 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1555611093 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555611098 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555611105 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS1555611110 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555611111 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555611136 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS1555611154 |
GRN
|
Health Risk |
Pathogenic/Likely pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS1555611253 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS1555611256 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS1555611293 |
GRN
|
Health Risk |
Pathogenic/Likely pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS1555611377 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS1555611412 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS1555611438 |
FLCN
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS1555611439 |
GRN
|
Health Risk |
Pathogenic |
— |
| RS1555611494 |
FLCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome 1 |
| RS1555611570 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1555611581 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555611584 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555611590 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555611610 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555611692 |
CHD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Snijders Blok-Campeau syndrome, Inborn genetic diseases |
| RS1555611722 |
CHD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Intellectual disability |
| RS1555612266 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555612270 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555612271 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555612273 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555612274 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555612276 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555612286 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555612288 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555612289 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555612294 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555612691 |
CHD3
|
Health Risk |
Likely pathogenic |
— |
| RS1555612815 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555612857 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555612859 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555612866 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555612867 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555613185 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555613190 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555613193 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555613200 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555613206 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555613421 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555613427 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1555613430 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555613541 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555613543 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555613555 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555613558 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555613564 |
MAPK7
|
Health Risk |
Pathogenic |
Scoliosis, isolated |
| RS1555613567 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555613598 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555613692 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1555613741 |
NF1
|
Health Risk |
Pathogenic |
Abnormality of the skin, Hereditary cancer-predisposing syndrome |
| RS1555613743 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555613773 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555613784 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555613786 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555613794 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555613795 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1555613801 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1555613810 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1555613811 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1555613816 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1555613821 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |